Fmr LLC Pharvaris N.V. Transaction History
Fmr LLC
- $1.52 Trillion
- Q2 2024
A detailed history of Fmr LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, Fmr LLC holds 5,205,656 shares of PHVS stock, worth $118 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,205,656
Previous 5,192,984
0.24%
Holding current value
$118 Million
Previous $120 Million
18.45%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding PHVS
# of Institutions
38Shares Held
37.8MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$170 Million4.48% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.29MShares$97.1 Million54.23% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$97 Million45.57% of portfolio
-
Viking Global Investors LP3.65MShares$82.6 Million0.27% of portfolio
-
Vr Adviser, LLC New York, NY3.4MShares$76.8 Million7.0% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $763M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...